Eligibility for clinical trials in primary Sjögren's syndrome: lessons from the UK Primary Sjögren's Syndrome Registry (Q40383414)

20 September 2017

Eligibility for clinical trials in primary Sjögren's syndrome: lessons from the UK Primary Sjögren's Syndrome Registry (English)

1 reference

20 September 2017

1 reference

0 references

Katherine James

3

0 references

Steven Young-Min

Steven Young-Min

26

0 references

Peter C Lanyon

Peter Lanyon

10

0 references

Francesca Barone

Francesca Barone

30

0 references

Saaeha Rauz

Saaeha Rauz

32

0 references

David A. Isenberg

21

David Isenberg

1 reference

20 September 2017

34

Simon J Bowman

1 reference

20 September 2017

14

Costantino Pitzalis

1 reference

20 September 2017

8

Colin T Pease

1 reference

20 September 2017

13

Nurhan Sutcliffe

1 reference

20 September 2017

28

Nagui Gendi

1 reference

20 September 2017

27

Robert Moots

1 reference

20 September 2017

12

Michele Bombardieri

1 reference

20 September 2017

4

Wan-Fai Ng

1 reference

20 September 2017

33

Andrea Richards

1 reference

20 September 2017

5

Bridget Griffiths

1 reference

20 September 2017

6

Victoria Hindmarsh

1 reference

20 September 2017

2

Sheryl Mitchell

1 reference

20 September 2017

L. Annie Cooper Smith

18

Annie Cooper

1 reference

20 September 2017

22

Vadivelu Saravanan

1 reference

20 September 2017

29

Mohammed Akil

1 reference

UK Primary Sjögren's Syndrome Registry

20 September 2017

35

UK Primary Sjögren’s Syndrome Registry

1 reference

20 September 2017

1

Clare Oni

1 reference

20 September 2017

Elizabeth Price

7

1 reference

20 September 2017

Adrian Jones

11

1 reference

20 September 2017

John Hunter

15

1 reference

20 September 2017

Monica Gupta

16

1 reference

20 September 2017

John McLaren

17

1 reference

20 September 2017

Marian Regan

19

1 reference

20 September 2017

Ian Giles

20

1 reference

20 September 2017

David Coady

23

1 reference

20 September 2017

Bhaskar Dasgupta

24

1 reference

20 September 2017

Neil McHugh

25

1 reference

20 September 2017

Ben Fisher

31

1 reference

20 September 2017

27 October 2015

1 reference

20 September 2017

1 reference

20 September 2017

55

1 reference

20 September 2017

3

1 reference

20 September 2017

544-552

1 reference

Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI).

20 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5854028

Biologic treatment in Sjögren's syndrome.

29 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5854028

Effects of hydroxychloroquine on symptomatic improvement in primary Sjögren syndrome: the JOQUER randomized clinical trial

29 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5854028

Treatment of primary Sjögren syndrome with rituximab: a randomized trial.

29 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5854028

The TRACTISS protocol: a randomised double blind placebo controlled clinical trial of anti-B-cell therapy in patients with primary Sjögren's Syndrome

29 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5854028

Primary Sjogren's syndrome as a multi-organ disease: impact of the serological profile on the clinical presentation of the disease in a large cohort of Italian patients.

29 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5854028

Efficacy and safety of belimumab in primary Sjögren's syndrome: results of the BELISS open-label phase II study

29 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5854028

Systemic involvement in primary Sjogren's syndrome evaluated by the EULAR-SS disease activity index: analysis of 921 Spanish patients (GEAS-SS Registry).

29 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5854028

EULAR Sjogren's Syndrome Disease Activity Index (ESSDAI) is sensitive to show efficacy of rituximab treatment in a randomised controlled trial

29 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5854028

Biologic treatments in Sjögren's syndrome

29 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5854028

Responsiveness of disease activity indices ESSPRI and ESSDAI in patients with primary Sjögren's syndrome treated with rituximab

29 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5854028

Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjögren's syndrome

29 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5854028

EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren's syndrome

29 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5854028

Whole stimulated salivary flow: correlation with the pathology of inflammation and damage in minor salivary gland biopsy specimens from patients with primary Sjögren's syndrome but not patients with sicca

29 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5854028

United Kingdom Primary Sjogren's Syndrome Registry--a united effort to tackle an orphan rheumatic disease

29 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5854028

Estimating indirect costs in primary Sjögren's syndrome.

29 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5854028

Effectiveness of rituximab treatment in primary Sjögren's syndrome: a randomized, double-blind, placebo-controlled trial.

29 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5854028

EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome

29 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5854028

Reduction of fatigue in Sjögren syndrome with rituximab: results of a randomised, double-blind, placebo-controlled pilot study.

29 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5854028

Long term remission of Sjögren's syndrome associated aggressive B cell non-Hodgkin's lymphomas following combined B cell depletion therapy and CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone).

29 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5854028

Inefficacy of infliximab in primary Sjögren's syndrome: results of the randomized, controlled Trial of Remicade in Primary Sjögren's Syndrome (TRIPSS).

29 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5854028

Measurement of fatigue and discomfort in primary Sjogren's syndrome using a new questionnaire tool.

29 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5854028

Window of opportunity in early rheumatoid arthritis: possibility of altering the disease process with early intervention.

29 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5854028

Quantitative ultrasonography and magnetic resonance imaging of the parotid gland: can they replace the histopathologic studies in patients with Sjogren's syndrome?

29 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5854028

Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group

29 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5854028

The Sjogren's Syndrome Damage Index--a damage index for use in clinical trials and observational studies in primary Sjogren's syndrome

29 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26510429

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Successful patient recruitment in investigator-led clinical trials

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26510429

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1093/RHEUMATOLOGY/KEV373

1 reference

10.1093/RHEUMATOLOGY/KEV373

20 September 2017

0 references

Dimensions Publication ID

0 references

0 references

1 reference